Deferasirox Improves Liver Pathology In β-Thalassemia Patients with Transfusional Iron Overload

被引：0
|
作者：
Deugnier, Yves [1 ]
Turlin, Bruno [2 ,3 ]
Dong, Victor [4 ]
Giannone, Vanessa [4 ]
Zhang, Yiyun [4 ]
Griffel, Louis [4 ]
Brissot, Pierre [1 ]
机构：
[1] Univ Hosp Pontchaillou, Liver Dis Unit, Rennes, France
[2] Univ Hosp Pontchaillou, INSERM, U991, Rennes, France
[3] Univ Hosp Pontchaillou, Dept Pathol, Biol Resource Ctr, Rennes, France
[4] Novartis Pharmaceut, E Hanover, NJ USA
来源：
BLOOD | 2010年 / 116卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1734 / 1735
页数：2
相关论文
共 50 条
  • [1] TREATMENT WITH DEFERASIROX FOR NON-TRANSFUSIONAL IRON OVERLOAD IN PATIENTS WITH THALASSEMIA INTERMEDIA
    Ladis, V.
    Berdoussi, H.
    Kattamis, A.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 509 - 509
  • [2] Effects of deferasirox-deferoxamine on myocardial and liver iron in patients with severe transfusional iron overload
    Aydinok, Yesim
    Kattamis, Antonis
    Cappellini, M. Domenica
    El-Beshlawy, Amal
    Origa, Raffaella
    Elalfy, Mohsen
    Kilinc, Yurdanur
    Perrotta, Silverio
    Karakas, Zeynep
    Viprakasit, Vip
    Habr, Dany
    Constantinovici, Niculae
    Shen, Junwu
    Porter, John B.
    [J]. BLOOD, 2015, 125 (25) : 3868 - 3877
  • [3] Management of Transfusional Chronic Iron Overload: Focus on Deferasirox
    Pilo, Federica
    Di Tucci, Anna Angela
    Dessi, Laura
    Angelucci, Emanuele
    [J]. CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2009, 1 : 735 - 745
  • [4] Deferasirox for the treatment of chronic iron overload in transfusional hemosiderosis
    Shashaty, George
    Frankewich, Raymond
    Chakraborti, Tamal
    Choudary, Jasti
    Al-Fayoumi, Suliman
    Kacuba, Alice
    Castillo, Sonia
    Robie-Suh, Kathy
    Rieves, Dwaine
    Weiss, Karen
    Pazdur, Richard
    [J]. ONCOLOGY-NEW YORK, 2006, 20 (14): : 1799 - +
  • [5] Deferiprone for the treatment of transfusional iron overload in thalassemia
    Belmont, Ami
    Kwiatkowski, Janet L.
    [J]. EXPERT REVIEW OF HEMATOLOGY, 2017, 10 (06) : 493 - 503
  • [6] Deferasirox for myelodysplastic syndrome patients with transfusional iron overload: A budget impact analysis
    Mody-Patel, N.
    Goldberg, S. L.
    Barghout, V.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [7] Deferasirox-associated Fanconi syndrome in adult patients with transfusional iron overload
    Yui, Jennifer C.
    Geara, Abdallah
    Sayani, Farzana
    [J]. VOX SANGUINIS, 2021, 116 (07) : 793 - 797
  • [8] Deferasirox improves hematologic and hepatic function with effective reduction of serum ferritin and liver iron concentration in transfusional iron overload patients with myelodysplastic syndrome or aplastic anemia
    Cheong, June-Won
    Kim, Hyeoung-Joon
    Lee, Kyoo-Hyung
    Yoon, Sung-Soo
    Lee, Jae Hoon
    Park, Hee-Sook
    Kim, Ho Young
    Shim, Hyeok
    Seong, Chu-Myung
    Kim, Chul Soo
    Chung, Jooseop
    Hyun, Myung Soo
    Jo, Deog-Yeon
    Jung, Chul Won
    Sohn, Sang Kyun
    Yoon, Hwi-Joong
    Kim, Byung Soo
    Joo, Young-Don
    Park, Chi-Young
    Min, Yoo Hong
    [J]. TRANSFUSION, 2014, 54 (06) : 1542 - 1551
  • [9] Deferasirox: A guide to its use in transfusional chronic iron overload
    不详
    [J]. Drugs & Therapy Perspectives, 2008, 24 (2) : 1 - 4
  • [10] Concomitant Medications and Gastrointestinal Events in Thalassemia and MDS Patients Receiving Deferasirox for Transfusional Iron Overload: Data From the EPIC Study
    Cappellini, M. Domenica
    El-Beshlawy, Amal
    Porter, John B.
    Kattamis, Antonis
    Taylor, Kerry
    Rose, Christian
    Louw, Vernon J.
    El-Ali, Ali
    Martin, Nicolas
    Gattermann, Norbert
    [J]. BLOOD, 2012, 120 (21)
12345